Catalyst Wire Dossier Catalyst Wire Dossier

CERETEC

TECHNETIUM TC-99M EXAMETAZIME; TECHNETIUM TC-99M EXAMETAZIME AND COBALTOUS CHLORIDE · Medi-Physics Inc. dba GE Healthcare.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CERETEC, covering 2013-03-08 to 2018-09-19. Get the full timeline:

Most recent: FDA Approved: CERETEC — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)

See pricing